Immunoglobulin E (IgE) ELISA
DRG International Inc.High Quality Assays with Reproducible and Reliable Results
High Quality Assays with Reproducible and Reliable Results
Modulation of cell signaling pathways offers an exciting avenue in the treatment of disease but first we need to learn the basics
New results suggest the MammaTyper test could predict the likelihood of complete pathologic remission
Non-invasive, cell-free pre-natal DNA testing to be performed on QIAGEN’s GeneReader NGS System
A blood test for cancer DNA could predict if a woman is responding to the new breast cancer drug palbociclib, months earlier than current tests
Institut Curie is one of an increasing number of major European cancer centers to become a co-validation partner for the new NGS-based MammaPrint BluePrint Kit
Watch industry leading scientists discuss the very latest developments in cancer research, made possible with digital PCR technology
SureSeq myPanel™ NGS Custom Cancer Panels enable researchers to create bespoke probe panels from an expert-curated library
Reference data set from Horizon affirms proven accuracy of GeneReader workflow
Professor Steve Estus discusses innovative research from his lab
Thermo Fisher Scientific’s Ion S5 systems provide a single solution for the widest range of targeted sequencing applications
Work conducted at Center to revolutionize diagnosis and treatment of cancer globally, selects Thermo Fisher Scientific as technology partner